DHR

Danaher Corporation New York Stock Exchange
$255.63
Open: $259.99 High: $260.01 Low: $254.67 Close: $256.515
Range: 2022-06-27 - 2022-06-28
Volume:492,815
Market: Open
DHR
Danaher Corporation 2200 PENNSYLVANIA AVE. N.W. https://www.danaher.com
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
  • CEO: Thomas P. Joyce
  • Employees: 80,000
  • Sector: Healthcare
  • Industry: Medical Diagnostics & Research
Latest Stocks Posts
Card image
Card image
Card image
DHR News
Latest news about the DHR